Male Institute of Cancer Research (ICR) mice aged 6–8 weeks were obtained from the National Laboratory Animal Centre (Taipei, Taiwan) and handled according to National Institutes of Health (NIH) Guides for the Care and Use of Laboratory Animals. ICR mice were anesthetized with ethyl ether and placed individually on a board in a near vertical position; the tongues were withdrawn with a lined forceps. S. aureus (2 × 107 CFU/mouse) was placed posterior in the throat and aspirated into lungs. Control mice were administrated BHI. Mice regained consciousness after 15 min. Mice were intraperitoneal given one dose of LY294002, SH-5, SP600125, U0126, Bay11-7082, or GR343 (2 mg/kg) or TLR2 or VCAM-1 neutralizing antibody (5 mg/kg) for 1 h or resveratrol (5 mg/kg) for 24 h prior to S. aureus (2 × 107 CFU/mouse) treatment, and sacrificed after 24 h.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.